(English) A healthy ecosystem cultivates powerful global collaboration
BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f
You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines.
Q: What's mRNA's superpower?
A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment.
Q: What's InnoRNA's superpower?
A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment.
Q: What's HKSTP's superpower?
A: Hong Kong is the world's number two biotech funding hub. We will leave you to find out more!
Follow our page for more biotech news in Hong Kong and beyond.
BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f
You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines.
Q: What's mRNA's superpower?
A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment.
Q: What's InnoRNA's superpower?
A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment.
Q: What's HKSTP's superpower?
A: Hong Kong is the world's number two biotech funding hub. We will leave you to find out more!
Follow our page for more biotech news in Hong Kong and beyond.
Reference : https://www.hkstp.org